NABOTA- BOTULINUM TOXIN TYPE A (200), BOTOX

Description

NABOTA- BOTULINUM TOXIN TYPE A (200), BOTOX

Botulinum toxin type A Nabota is indicated for the temporary treatment of glabellar lines associated with cardboard lines and / or decreased abdominal muscle activity in adult patients less than 65 years of age. Botulinum toxin type A (Nabota) is indicated for the treatment of focal armpit hyperhidrosis.

Description

Botulinum toxin type A (Nabota) is indicated for the temporary improvement in the appearance of the upper respiratory tract (forehead lines, crow’s feet and forehead lines) in adults. Botulinum toxin type A (Nabota) is indicated for the prevention of headaches in adults with chronic migraine.

Botulinum toxin type A (Nabota) is indicated for the treatment of urinary incontinence due to neurogenic detrusor overactivity, e.g., spinal cord injury (SCI) or multiple sclerosis (MI) in adults.

INDICATION

• Temporary improvement in the appearance of moderate to severe glabellar lines associated with ripple and / or lower abdominal activity in adult patients (CoR, US, EU, Canada approved)
• Treatment of upper limb spasticity in adult patients (CoR approved)
• Transient improvement in the appearance of moderate to severe lateral angular lines associated with ocular activity in adult patients (CoR approved)
• Treatment of dystonia-related blepharospasm in adult patients (KR approved)

HI Pure TM technology

Composition: volume – 200 units